JAZZ
Jazz Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
JAZZ fundamentals
During Q4 2025, Jazz Pharmaceuticals (JAZZ) reported revenue of 1.20B, a YoY change of 10.09%. Net income was 203.45M, a YoY change of 6.45%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q1,2016 | Q2,2016 | Q3,2016 | Q4,2016 | Q1,2017 | Q2,2017 | Q3,2017 | Q4,2017 | Q1,2018 | Q2,2018 | Q3,2018 | Q4,2018 | Q1,2019 | Q2,2019 | Q3,2019 | Q4,2019 | Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Jan 1, 2016 | Apr 1, 2016 | Jul 1, 2016 | Oct 1, 2016 | Jan 1, 2017 | Apr 1, 2017 | Jul 1, 2017 | Oct 1, 2017 | Jan 1, 2018 | Apr 1, 2018 | Jul 1, 2018 | Oct 1, 2018 | Jan 1, 2019 | Apr 1, 2019 | Jul 1, 2019 | Oct 1, 2019 | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Mar 31, 2016 | Jun 30, 2016 | Sep 30, 2016 | Dec 31, 2016 | Mar 31, 2017 | Jun 30, 2017 | Sep 30, 2017 | Dec 31, 2017 | Mar 31, 2018 | Jun 30, 2018 | Sep 30, 2018 | Dec 31, 2018 | Mar 31, 2019 | Jun 30, 2019 | Sep 30, 2019 | Dec 31, 2019 | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | 336.01M +8.63% | 381.16M +14.21% | 374.18M +9.77% | 396.62M +16.35% | 376.05M +11.92% | 394.39M +3.47% | 411.86M +10.07% | 436.40M +10.03% | 444.61M +18.23% | 500.48M +26.90% | 469.37M +13.97% | 476.46M +9.18% | 508.19M +14.30% | 534.13M +6.72% | 537.70M +14.56% | 581.74M +22.10% | 534.73M +5.22% | 562.44M +5.30% | 600.89M +11.75% | 665.52M +14.40% | 607.58M +13.62% | 751.81M +33.67% | 838.12M +39.48% | 896.73M +34.74% | 813.72M +33.93% | 932.88M +24.08% | 940.65M +12.23% | 972.12M +8.41% | 892.81M +9.72% | 957.32M +2.62% | 972.14M +3.35% | 1.01B +4.10% | 901.98M +1.03% | 1.02B +6.95% | 1.05B +8.52% | 1.09B +7.53% | 897.84M -0.46% | 1.05B +2.14% | 1.13B +6.74% | 1.20B +10.09% | 4.27B -- |
Sales and Services Revenue | 336.01M +8.63% | 381.16M +14.21% | 374.18M +9.77% | 396.62M +16.35% | 376.05M +11.92% | 394.39M +3.47% | 411.86M +10.07% | 436.40M +10.03% | 444.61M +18.23% | 500.48M +26.90% | 469.37M +13.97% | 476.46M +9.18% | 508.19M +14.30% | 534.13M +6.72% | 537.70M +14.56% | 581.74M +22.10% | 534.73M +5.22% | 562.44M +5.30% | 600.89M +11.75% | 665.52M +14.40% | 607.58M +13.62% | 751.81M +33.67% | 838.12M +39.48% | 896.73M +34.74% | 813.72M +33.93% | 932.88M +24.08% | 940.65M +12.23% | 972.12M +8.41% | 892.81M +9.72% | 957.32M +2.62% | 972.14M +3.35% | 1.01B +4.10% | 901.98M +1.03% | 1.02B +6.95% | 1.05B +8.52% | 1.09B +7.53% | 897.84M -0.46% | 1.05B +2.14% | 1.13B +6.74% | 1.20B +10.09% | 4.27B -- |
Cost of Revenue | 23.44M -17.17% | 23.98M +9.93% | 24.31M -14.35% | 33.66M +40.06% | -- -- | 28.67M +19.57% | 31.20M +28.35% | 25.25M -24.98% | 33.92M -- | 34.71M +21.07% | 26.57M -14.84% | 26.34M +4.31% | 33.51M -1.22% | 27.68M -20.27% | 31.40M +18.16% | 35.35M +34.21% | 28.66M -14.47% | 28.01M +1.20% | 42.09M +34.06% | 50.16M +41.89% | 40.19M +40.24% | 119.19M +325.57% | 145.22M +244.99% | 136.15M +171.45% | 115.28M +186.85% | 124.21M +4.21% | 133.66M -7.96% | 167.36M +22.92% | 128.64M +11.59% | 97.54M -21.47% | 102.15M -23.57% | 107.24M -35.92% | 95.49M -25.77% | 109.90M +12.68% | 111.61M +9.26% | 128.71M +20.02% | 104.62M +9.56% | 116.27M +5.79% | 128.88M +15.47% | 153.53M +19.28% | 503.30M -- |
Cost of Goods and Services | -- -- | -- -- | -- -- | 105.39M -- | -- -- | -- -- | -- -- | 110.19M +4.56% | -- -- | -- -- | -- -- | 121.54M +10.31% | 33.51M -- | 27.68M -- | 31.40M -- | 35.35M -70.92% | 28.66M -14.47% | 28.01M +1.20% | 42.09M +34.06% | 50.16M +41.89% | 40.19M +40.24% | 119.19M +325.57% | 145.22M +244.99% | 136.15M +171.45% | 115.28M +186.85% | 124.21M +4.21% | 133.66M -7.96% | 167.36M +22.92% | 128.64M +11.59% | 97.54M -21.47% | 102.15M -23.57% | 107.24M -35.92% | 95.49M -25.77% | 109.90M +12.68% | 111.61M +9.26% | 128.71M +20.02% | 104.62M +9.56% | 116.27M +5.79% | 128.88M +15.47% | 153.53M +19.28% | 503.30M -- |
Gross Profit | 312.57M +11.23% | 357.18M +14.51% | 349.87M +11.96% | 362.96M +14.55% | 376.05M +20.31% | 365.71M +2.39% | 380.65M +8.80% | 411.15M +13.28% | 410.69M +9.21% | 465.76M +27.36% | 442.80M +16.33% | 450.12M +9.48% | 474.68M +15.58% | 506.46M +8.74% | 506.30M +14.34% | 546.39M +21.39% | 506.07M +6.61% | 534.43M +5.52% | 558.79M +10.37% | 615.36M +12.62% | 567.39M +12.12% | 632.62M +18.37% | 692.89M +24.00% | 760.58M +23.60% | 698.44M +23.10% | 808.67M +27.83% | 806.99M +16.47% | 804.76M +5.81% | 764.17M +9.41% | 859.78M +6.32% | 869.99M +7.81% | 904.69M +12.42% | 806.50M +5.54% | 913.92M +6.30% | 943.36M +8.43% | 959.46M +6.05% | 793.22M -1.65% | 929.44M +1.70% | 997.23M +5.71% | 1.04B +8.85% | 3.76B -- |
Operating Expenses | 191.41M +16.54% | 188.45M +18.79% | 213.62M +18.05% | 197.46M -6.07% | 239.91M +25.34% | 200.67M +6.49% | 294.20M +37.72% | 269.95M +36.71% | 322.89M +34.59% | 312.57M +55.76% | 254.02M -13.66% | 265.06M -1.81% | 340.94M +5.59% | 302.17M -3.32% | 373.20M +46.92% | 485.15M +83.03% | 695.74M +104.07% | 336.30M +11.29% | 362.59M -2.84% | 441.95M -8.90% | 405.27M -41.75% | 702.21M +108.80% | 664.52M +83.27% | 711.20M +60.92% | 610.89M +50.73% | 723.12M +2.98% | 782.23M +17.71% | 1.07B +50.19% | 638.11M +4.46% | 702.14M -2.90% | 697.60M -10.82% | 782.20M -26.77% | 740.29M +16.01% | 714.48M +1.76% | 683.15M -2.07% | 768.69M -1.73% | 849.11M +14.70% | 1.62B +126.16% | 939.72M +37.56% | 789.86M +2.75% | 4.19B -- |
Selling, General and Administrative Expenses | 151.41M +10.46% | 149.35M +14.19% | 150.82M +15.86% | 153.30M +2.72% | 194.99M +28.78% | 158.51M +6.13% | 171.84M +13.93% | 195.95M +27.82% | 260.22M +33.46% | 213.54M +34.71% | 202.86M +18.06% | 208.41M +6.36% | 224.83M -13.60% | 237.59M +11.26% | 241.57M +19.08% | 387.76M +86.06% | 271.25M +20.64% | 254.38M +7.07% | 273.94M +13.40% | 314.25M -18.96% | 328.70M +21.18% | 569.51M +123.88% | 523.49M +91.10% | 555.75M +76.85% | 480.91M +46.31% | 514.93M -9.58% | 499.71M -4.54% | 520.59M -6.33% | 447.70M -6.90% | 492.91M -4.28% | 463.19M -7.31% | 547.59M +5.19% | 507.44M +13.34% | 493.75M +0.17% | 483.23M +4.33% | 528.19M -3.54% | 668.46M +31.73% | 520.50M +5.42% | 699.01M +44.66% | 575.95M +9.04% | 2.46B -- |
Research and Development Expenses | 40.00M +47.17% | 39.09M +40.45% | 47.80M -5.88% | 44.16M +49.92% | 44.93M +12.31% | 42.16M +7.84% | 47.36M -0.91% | 66.00M +49.45% | 62.67M +39.48% | 56.13M +33.15% | 51.16M +8.02% | 56.66M -14.15% | 116.11M +85.27% | 64.58M +15.06% | 131.63M +157.29% | -12.59M -122.23% | 288.36M +148.36% | 81.92M +26.85% | 88.65M -32.65% | -123.55M -881.11% | 76.57M -73.45% | 132.70M +61.98% | 141.04M +59.10% | 155.44M +225.81% | 129.98M +69.75% | 208.19M +56.90% | 148.87M +5.55% | 103.41M -33.48% | 190.41M +46.49% | 209.24M +0.50% | 234.40M +57.45% | 216.61M +109.47% | 222.85M +17.04% | 220.73M +5.49% | 199.92M -14.71% | 240.50M +11.03% | 180.65M -18.93% | 1.10B +396.22% | 198.20M -0.86% | 213.91M -11.06% | 1.69B -- |
Loss on Impairment of Other Assets | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 42.90M -- | 0 -- | 0 -- | 0 -- | 0 -100.00% | 136.14M -- | 0 -- | 0 -- | 0 -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | -- -- | 133.65M -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Other Operating Expenses | -- -- | -- -- | 15.00M -- | 0 -100.00% | -- -- | -- -- | 75.00M +400.00% | 8.00M -- | 0 -- | 42.90M -- | 0 -100.00% | -42.90M -636.20% | -- -- | -- -- | -- -- | 109.97M +356.38% | -- -- | -- -- | -- -- | 251.25M +128.46% | -- -- | -- -- | -- -- | 0 -100.00% | -- -- | -- -- | -- -- | 444.15M -- | -- -- | -- -- | 0 -- | 18.00M -95.95% | 10.00M -- | -- -- | 0 -- | 0 -100.00% | 0 -100.00% | -- -- | 42.50M -- | 0 -- | -- -- |
Operating Income | 121.16M +3.77% | 168.74M +10.07% | 136.25M +3.59% | 165.50M +55.22% | 136.14M +12.36% | 165.04M -2.19% | 86.45M -36.55% | 141.21M -14.68% | 87.81M -35.50% | 153.20M -7.18% | 188.78M +118.36% | 185.06M +31.05% | 133.74M +52.31% | 204.28M +33.34% | 133.10M -29.49% | 61.24M -66.90% | -189.67M -241.82% | 198.13M -3.01% | 196.21M +47.41% | 173.41M +183.15% | 162.12M +185.47% | -69.59M -135.12% | 28.37M -85.54% | 49.38M -71.52% | 87.55M -46.00% | 85.55M +222.93% | 24.76M -12.71% | -263.39M -633.39% | 126.06M +43.98% | 157.64M +84.27% | 172.39M +596.17% | 122.50M +146.51% | 66.21M -47.48% | 199.44M +26.52% | 260.21M +50.94% | 190.77M +55.73% | -55.89M -184.42% | -686.39M -444.15% | 57.51M -77.90% | 254.53M +33.43% | -430.24M -- |
Non-Operating Income (Loss) | -13.01M +7.06% | -12.12M +64.91% | -19.99M -46.68% | -14.47M -42.97% | -20.47M -57.32% | -23.92M -97.38% | -21.69M -8.51% | -22.65M -56.58% | -22.67M -10.75% | -24.35M -1.80% | -20.11M +7.27% | -20.44M +9.76% | -19.43M +14.31% | -21.04M +13.63% | -19.92M +0.94% | -21.78M -6.53% | -19.45M -0.10% | -28.57M -35.83% | -28.69M -44.00% | -29.23M -34.24% | -22.27M -14.51% | -65.11M -127.87% | -99.26M -245.97% | -97.20M -232.49% | -85.37M -283.36% | -66.99M -2.90% | -87.44M +11.91% | -77.38M +20.39% | -71.96M +15.71% | -77.52M -15.72% | -72.75M +16.80% | -61.43M +20.61% | -69.16M +3.90% | -61.53M +20.63% | -59.69M +17.95% | -57.57M +6.29% | -54.46M +21.25% | -49.25M +19.96% | -48.52M +18.71% | -46.12M +19.88% | -198.35M -- |
Income (Loss) from Affiliates | -- -- | -- -- | -103.00K -- | -276.00K -- | -161.00K -- | -203.00K -- | -273.00K -165.05% | -372.00K -34.78% | -337.00K -109.32% | -586.00K -188.67% | -437.00K -60.07% | -843.00K -126.61% | -893.00K -164.99% | -868.00K -48.12% | -1.03M -135.70% | -1.30M -53.97% | 182.00K +120.38% | -1.90M -118.55% | -623.00K +39.51% | -624.00K +51.93% | 4.17M +2188.46% | 1.36M +171.96% | -3.26M -422.63% | -2.99M -378.85% | -4.14M -199.45% | -2.46M -280.29% | -2.54M +21.84% | -773.00K +74.13% | -1.00M +75.74% | -1.67M +32.18% | 126.00K +104.95% | -461.00K +40.36% | -1.35M -34.03% | -12.00K +99.28% | -285.00K -326.19% | -16.00K +96.53% | -542.00K +59.76% | -86.00K -616.67% | -47.00K +83.51% | -57.00K -256.25% | -732.00K -- |
Gain (Loss) on Foreign Currency Exchange | -- -- | -- -- | -- -- | 3.37M -- | -- -- | -- -- | -- -- | -9.97M -395.64% | -- -- | -- -- | -- -- | -6.88M +31.04% | -611.00K -- | -1.93M -- | -1.03M -- | -2.23M +67.51% | -1.13M -85.27% | -464.00K +76.00% | -639.00K +38.14% | -1.04M +53.63% | 943.00K +183.30% | 2.95M +735.78% | -2.63M -311.74% | -5.61M -441.70% | -10.54M -1217.71% | -1.34M -145.53% | -4.65M -76.70% | -2.48M +55.77% | 3.19M +130.29% | -2.38M -77.36% | -1.38M +70.38% | 9.35M +476.83% | -1.69M -153.02% | 507.00K +121.28% | -701.00K +49.09% | -6.29M -167.30% | -213.00K +87.42% | -1.80M -454.83% | 102.00K +114.55% | -658.00K +89.55% | -2.57M -- |
Other Non-Operating Income (Loss) | -819.00K -136.48% | -- -- | -1.39M -41.97% | 1.57M -25.01% | -1.46M -78.75% | -5.43M -- | -2.22M -60.35% | 9.12M +481.31% | -1.73M -18.03% | -4.12M +24.05% | -756.00K +66.01% | 6.61M -27.53% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Interest Expense | 12.19M -24.95% | 12.12M -23.34% | 18.50M +46.23% | 19.13M +56.68% | 18.84M +54.56% | 18.29M +50.93% | 19.19M +3.75% | 21.43M +12.00% | 20.61M +9.35% | 19.65M +7.39% | 18.92M -1.42% | 19.33M -9.79% | 17.92M -13.02% | 18.23M -7.19% | 17.86M -5.60% | 18.24M -5.61% | 18.50M +3.20% | 26.21M +43.74% | 27.43M +53.56% | 27.57M +51.13% | 27.38M +48.01% | 69.42M +164.86% | 93.37M +240.43% | 88.60M +221.32% | 70.68M +158.20% | 63.19M -8.98% | 80.24M -14.06% | 74.13M -16.34% | 74.15M +4.90% | 73.47M +16.27% | 71.50M -10.90% | 70.32M -5.13% | 66.12M -10.83% | 62.02M -15.58% | 58.70M -17.90% | 51.26M -27.11% | 53.71M -18.77% | 47.36M -23.64% | 48.58M -17.25% | 45.41M -11.41% | 195.05M -- |
Pretax Income From Continuing Operations | 108.15M +5.25% | 156.61M +31.87% | 116.27M -1.39% | 151.04M +56.50% | 115.67M +6.95% | 141.12M -9.89% | 64.77M -44.30% | 118.55M -21.51% | 65.14M -43.69% | 128.84M -8.70% | 168.66M +160.42% | 164.61M +38.85% | 114.32M +75.50% | 183.25M +42.22% | 113.18M -32.90% | 39.47M -76.02% | -209.12M -282.93% | 169.56M -7.47% | 167.52M +48.01% | 144.18M +265.30% | 139.85M +166.88% | -134.69M -179.44% | -70.89M -142.32% | -47.82M -133.17% | 2.18M -98.44% | 18.55M +113.77% | -62.67M +11.59% | -340.77M -612.63% | 54.10M +2378.06% | 80.11M +331.82% | 99.64M +258.99% | 61.06M +117.92% | -2.95M -105.45% | 137.91M +72.15% | 200.52M +101.24% | 133.20M +118.13% | -110.35M -3642.05% | -735.64M -633.40% | 8.99M -95.52% | 208.41M +56.46% | -628.59M -- |
Income Tax Expense | 32.34M +0.87% | 42.11M +37.41% | 26.44M -11.71% | 34.35M +149.84% | 29.16M -9.83% | 35.52M -15.67% | 1.24M -95.31% | -113.65M -430.89% | 19.15M -34.34% | 36.52M +2.84% | 19.35M +1461.58% | 5.14M +104.53% | 29.12M +52.07% | -78.65M -315.34% | 10.90M -43.65% | -34.52M -771.13% | -51.29M -276.15% | 54.75M +169.62% | 19.28M +76.86% | 10.77M +131.19% | 18.02M +135.13% | 228.62M +317.54% | -18.06M -193.64% | -12.47M -215.79% | 536.00K -97.03% | -16.11M -107.05% | -43.03M -138.28% | -100.04M -702.45% | -15.32M -2958.96% | -24.32M -50.96% | -47.18M -9.64% | -33.09M +66.92% | 11.67M +176.15% | -30.65M -26.02% | -14.53M +69.19% | -57.91M -75.02% | -17.81M -252.64% | -17.17M +43.99% | -242.42M -1568.09% | 4.96M +108.57% | -272.44M -- |
Current Income Tax | -- -- | -- -- | -- -- | 176.40M -- | -- -- | -- -- | -- -- | 177.85M +0.82% | -- -- | -- -- | -- -- | 168.98M -4.99% | -- -- | -- -- | -- -- | 163.46M -3.27% | -- -- | -- -- | -- -- | 170.45M +4.28% | -- -- | -- -- | -- -- | 146.92M -13.81% | -- -- | -- -- | -- -- | 133.61M -9.06% | -- -- | -- -- | -- -- | 140.31M +5.01% | -- -- | -- -- | -- -- | 116.90M -16.68% | -- -- | -- -- | -- -- | 172.53M +47.59% | -- -- |
Deferred Income Tax | -- -- | -- -- | -- -- | -41.16M -- | -- -- | -- -- | -- -- | -225.59M -448.04% | -- -- | -- -- | -- -- | -88.81M +60.63% | -- -- | -- -- | -- -- | -236.61M -166.41% | -- -- | -- -- | -- -- | -136.94M +42.13% | -- -- | -- -- | -- -- | 69.20M +150.53% | -- -- | -- -- | -- -- | -292.25M -522.34% | -- -- | -- -- | -- -- | -260.22M +10.96% | -- -- | -- -- | -- -- | -208.33M +19.94% | -- -- | -- -- | -- -- | -444.97M -113.59% | -- -- |
Net Income | 75.81M +7.23% | 114.50M +29.95% | 89.83M +2.12% | 116.69M +41.00% | 86.51M +14.11% | 105.60M -7.77% | 63.53M -29.28% | 232.21M +99.00% | 45.99M -46.84% | 92.32M -12.58% | 149.32M +135.05% | 159.47M -31.32% | 85.20M +85.26% | 261.90M +183.68% | 102.28M -31.50% | 73.99M -53.60% | -157.83M -285.25% | 114.80M -56.17% | 148.23M +44.94% | 133.41M +80.31% | 121.83M +177.19% | -363.32M -416.47% | -52.83M -135.64% | -35.35M -126.50% | 1.65M -98.65% | 34.66M +109.54% | -19.65M +62.81% | -240.72M -580.95% | 69.42M +4114.94% | 104.44M +201.28% | 146.82M +847.25% | 94.15M +139.11% | -14.62M -121.06% | 168.57M +61.40% | 215.06M +46.48% | 191.12M +102.98% | -92.54M -533.06% | -718.47M -526.22% | 251.41M +16.91% | 203.45M +6.45% | -356.15M -- |
Net Income Attributable to Owners of the Company | 75.81M +7.23% | 114.50M +29.95% | 89.83M +2.12% | 116.69M +41.00% | 86.51M +14.11% | 105.60M -7.77% | 63.53M -29.28% | 232.21M +99.00% | 45.99M -46.84% | 92.32M -12.58% | 149.32M +135.05% | 159.47M -31.32% | 85.20M +85.26% | 261.90M +183.68% | 102.28M -31.50% | 73.99M -53.60% | -157.83M -285.25% | 114.80M -56.17% | 148.23M +44.94% | 133.41M +80.31% | 121.83M +177.19% | -363.32M -416.47% | -52.83M -135.64% | -35.35M -126.50% | 1.65M -98.65% | 34.66M +109.54% | -19.65M +62.81% | -240.72M -580.95% | 69.42M +4114.94% | 104.44M +201.28% | 146.82M +847.25% | 94.15M +139.11% | -14.62M -121.06% | 168.57M +61.40% | 215.06M +46.48% | 191.12M +102.98% | -92.54M -533.06% | -718.47M -526.22% | 251.41M +16.91% | 203.45M +6.45% | -356.15M -- |
Net Income Attributable to Common Stockholders | 75.81M +7.23% | 114.50M +29.95% | 89.83M +2.12% | 116.69M +41.00% | 86.51M +14.11% | 105.60M -7.77% | 63.53M -29.28% | 232.21M +99.00% | 45.99M -46.84% | 92.32M -12.58% | 149.32M +135.05% | 159.47M -31.32% | 85.20M +85.26% | 261.90M +183.68% | 102.28M -31.50% | 73.99M -53.60% | -157.83M -285.25% | 114.80M -56.17% | 148.23M +44.94% | 133.41M +80.31% | 121.83M +177.19% | -363.32M -416.47% | -52.83M -135.64% | -35.35M -126.50% | 1.65M -98.65% | 34.66M +109.54% | -19.65M +62.81% | -240.72M -580.95% | 69.42M +4114.94% | 104.44M +201.28% | 146.82M +847.25% | 94.15M +139.11% | -14.62M -121.06% | 168.57M +61.40% | 215.06M +46.48% | 191.12M +102.98% | -92.54M -533.06% | -718.47M -526.22% | 251.41M +16.91% | 203.45M +6.45% | -356.15M -- |
Other Comprehensive Income | 45.19M +128.87% | -27.70M -190.70% | 14.61M -12.91% | -81.96M -126.39% | 17.49M -61.30% | 89.59M +423.40% | 51.26M +250.82% | 18.11M +122.10% | 42.06M +140.46% | -69.46M -177.53% | -11.24M -121.92% | -18.32M -201.19% | -22.88M -154.41% | 10.24M +114.74% | -49.01M -336.07% | 36.05M +296.72% | -34.04M -48.77% | 21.33M +108.31% | 48.31M +198.58% | 53.45M +48.27% | -45.08M -32.41% | -11.51M -153.96% | -206.58M -527.64% | -2.84M -105.32% | -190.36M -322.31% | -515.31M -4378.22% | -511.62M -147.66% | 492.14M +17410.48% | 145.28M +176.32% | 113.41M +122.01% | -168.58M +67.05% | -- -- | -40.25M -127.70% | -5.83M -105.14% | 284.83M +268.96% | -344.27M -- | 162.06M +502.66% | 299.84M +5240.44% | -84.13M -129.54% | 1.30M +100.38% | 379.07M -- |
Total Comprehensive Income | 121.00M +241.03% | 86.80M -26.85% | 104.44M -0.29% | 34.73M -25.40% | 104.00M -14.05% | 195.20M +124.89% | 114.79M +9.91% | 250.32M +620.71% | 88.05M -15.34% | 22.86M -88.29% | 138.08M +20.29% | 141.15M -43.61% | 62.32M -29.22% | 272.14M +1090.39% | 53.27M -61.42% | 110.04M -22.04% | -191.88M -407.90% | 136.13M -49.98% | 196.54M +268.95% | 186.86M +69.81% | 76.76M +140.00% | -374.82M -375.35% | -259.42M -231.99% | -38.19M -120.44% | -188.71M -345.86% | -480.64M -28.23% | -531.26M -104.79% | 251.41M +758.25% | 214.70M +213.77% | 217.84M +145.32% | -21.76M +95.90% | -- -- | -54.87M -125.55% | 162.74M -25.30% | 499.88M +2397.69% | -153.16M -- | 69.52M +226.70% | -418.63M -357.25% | 167.28M -66.54% | 204.75M +233.69% | 22.92M -- |
Total Comprehensive Income Attributable to Owners of the Company | 121.00M +241.05% | 86.80M -26.85% | 104.44M -0.27% | 34.73M -25.41% | 104.00M -14.05% | 195.20M +124.89% | 114.79M +9.91% | 250.32M +620.71% | 88.05M -15.34% | 22.86M -88.29% | 138.08M +20.29% | 141.15M -43.61% | 62.32M -29.22% | 272.14M +1090.39% | 53.27M -61.42% | 110.04M -22.04% | -191.88M -407.90% | 136.13M -49.98% | 196.54M +268.95% | 186.86M +69.81% | 76.76M +140.00% | -374.82M -375.35% | -259.42M -231.99% | -38.19M -120.44% | -188.71M -345.86% | -480.64M -28.23% | -531.26M -104.79% | 251.41M +758.25% | 214.70M +213.77% | 217.84M +145.32% | -21.76M +95.90% | 287.41M +14.32% | -54.87M -125.55% | 162.74M -25.30% | 499.88M +2397.69% | -153.16M -153.29% | 69.52M +226.70% | -418.63M -357.25% | 167.28M -66.54% | 204.75M +233.69% | 22.92M -- |
Basic EPS | 1.24 +6.90% | 1.89 +31.25% | 1.49 +4.20% | 1.95 +44.44% | 1.44 +16.13% | 1.76 -6.88% | 1.06 -28.86% | 3.88 +98.97% | 0.77 -46.53% | 1.53 -13.07% | 2.47 +133.02% | 2.77 -28.61% | 1.49 +93.51% | 4.62 +201.96% | 1.8 -27.13% | 1.32 -52.35% | -2.82 -289.26% | 2.07 -55.19% | 2.67 +48.33% | 2.38 +80.30% | 2.16 +176.60% | -6.11 -395.17% | -0.86 -132.21% | -0.57 -123.95% | 0.03 -98.61% | 0.56 +109.17% | -0.31 +63.95% | -3.81 -568.42% | 1.09 +3533.33% | 1.63 +191.07% | 2.33 +851.61% | 1.5 +139.37% | -0.23 -121.10% | 2.68 +64.42% | 3.5 +50.21% | 3.15 +110.00% | -1.52 -560.87% | -11.74 -538.06% | 4.14 +18.29% | 3.31 +5.08% | -5.81 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 1.49 -- | 4.62 -- | 1.8 -- | -- -- | -2.82 -289.26% | 2.07 -55.19% | 2.67 +48.33% | -- -- | 2.16 +176.60% | -6.11 -395.17% | -0.86 -132.21% | -- -- | 0.03 -98.61% | 0.56 +109.17% | -0.31 +63.95% | -- -- | 1.09 +3533.33% | 1.63 +191.07% | 2.33 +851.61% | -- -- | -0.23 -121.10% | 2.68 +64.42% | 3.5 +50.21% | -- -- | -1.52 -560.87% | -11.74 -538.06% | 4.14 +18.29% | -- -- | -- -- |
Diluted EPS | 1.21 +8.04% | 1.85 +32.14% | 1.45 +4.32% | -- -- | 1.41 +16.53% | 1.72 -7.03% | 1.03 -28.97% | -- -- | 0.75 -46.81% | 1.5 -12.79% | 2.41 +133.98% | -- -- | 1.47 +96.00% | 4.56 +204.00% | 1.78 -26.14% | -- -- | -2.82 -291.84% | 2.06 -54.82% | 2.64 +48.31% | -- -- | 2.09 +174.11% | -6.11 -396.60% | -0.86 -132.58% | -- -- | 0.03 -98.56% | 0.55 +109.00% | -0.31 +63.95% | -- -- | 1.04 +3366.67% | 1.52 +176.36% | 2.14 +790.32% | 1.42 -- | -0.23 -122.12% | 2.49 +63.82% | 3.42 +59.81% | -- -- | -1.52 -560.87% | -11.74 -571.49% | 4.08 +19.30% | -- -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 1.47 -- | 4.56 -- | 1.78 -- | -- -- | -2.82 -291.84% | 2.06 -54.82% | 2.64 +48.31% | -- -- | 2.09 +174.11% | -6.11 -396.60% | -0.86 -132.58% | -- -- | 0.03 -98.56% | 0.55 +109.00% | -0.31 +63.95% | -- -- | 1.04 +3366.67% | 1.52 +176.36% | 2.14 +790.32% | -- -- | -0.23 -122.12% | 2.49 +63.82% | 3.42 +59.81% | -- -- | -1.52 -560.87% | -11.74 -571.49% | 4.08 +19.30% | -- -- | -- -- |
You can ask Aime
What is the market's earnings forecast for Jazz Pharmaceuticals next quarter?What is the revenue and EPS growth rate for Jazz Pharmaceuticals year over year?Did Jazz Pharmaceuticals beat or miss consensus estimates last quarter?What does Jazz Pharmaceuticals do and what are its main business segments?What is Jazz Pharmaceuticals's latest dividend and current dividend yield?What were the key takeaways from Jazz Pharmaceuticals's earnings call?What were the key takeaways from Jazz Pharmaceuticals’s earnings call?What is Jazz Pharmaceuticals's gross profit margin?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
